Foghorn Therapeutics Inc.
FHTX
$4.36
$0.369.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.94% | 12.78% | 13.46% | 11.99% | 11.61% |
| Total Depreciation and Amortization | 2.49% | -5.09% | -9.19% | -9.59% | -6.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -26.08% | -36.77% | -18.17% | -18.07% | -15.49% |
| Change in Net Operating Assets | 1.01% | 33.50% | 27.55% | 22.95% | 18.65% |
| Cash from Operations | 14.58% | 17.46% | 18.27% | 14.99% | 13.44% |
| Capital Expenditure | -14.01% | -253.59% | -20.90% | 25.98% | 68.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -200.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 947.88% | -70.59% | -118.75% | -119.91% | -114.06% |
| Cash from Investing | 917.68% | -71.49% | -119.43% | -120.70% | -114.73% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.58% | -98.27% | 3,592.75% | 5,862.49% | 6,504.17% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -100.00% | -- | -- | -- |
| Cash from Financing | -99.58% | -98.63% | 3,572.18% | 5,829.58% | 6,467.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 362.89% | -179.80% | -163.70% | -188.48% | 27.10% |